. Author manuscript; available in PMC: 2020 Jul 1.

Published in final edited form as: Breast Cancer Res Treat. 2019 Apr 13;176(1):101–108. doi: 10.1007/s10549-019-05224-w

Table 3a.

Rate of Pathologic Concordance with Clinical Expectation

	N (% of Total) (N=366)
Pathologically Discordant^*	297 (81.1%)
Pathologically Concordant^#	69 (18.9%)

Includes: fibroadenoma, hamartoma, PASH, adenoma, benign breast tissue, focal sclerosis, lipoma, focal juvenile hypertrophy, fibrocystic changes

Includes: benign phyllodes, juvenile/cellular fibroadenoma, juvenile papillomatosis/intraductal papilloma, abscess